chr7-31554895-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001257967.3(ITPRID1):c.250C>T(p.Arg84Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000206 in 1,578,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001257967.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ITPRID1 | NM_001257967.3 | c.250C>T | p.Arg84Cys | missense_variant | 5/15 | ENST00000615280.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ITPRID1 | ENST00000615280.5 | c.250C>T | p.Arg84Cys | missense_variant | 5/15 | 2 | NM_001257967.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152080Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000308 AC: 63AN: 204828Hom.: 0 AF XY: 0.000303 AC XY: 33AN XY: 108850
GnomAD4 exome AF: 0.000211 AC: 301AN: 1426716Hom.: 0 Cov.: 29 AF XY: 0.000221 AC XY: 156AN XY: 706680
GnomAD4 genome AF: 0.000164 AC: 25AN: 152080Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74274
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.250C>T (p.R84C) alteration is located in exon 4 (coding exon 3) of the CCDC129 gene. This alteration results from a C to T substitution at nucleotide position 250, causing the arginine (R) at amino acid position 84 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at